Morphological and biochemical action of dipyrone on rat placenta

被引:8
作者
Espiridiao, S
Oliveira, RM
Doine, A
Simoes, MJ
Focchi, GRA
Neto, JE
Kopelman, BI
Kulay, L
机构
[1] UNIV SAO PAULO,INST BIOMED SCI,BR-04023900 SAO PAULO,BRAZIL
[2] UNIV SAO PAULO,ESCOLA PAULISTA MED,BR-04023900 SAO PAULO,BRAZIL
来源
GENERAL PHARMACOLOGY | 1996年 / 27卷 / 03期
关键词
rat; placenta; pregnancy; dipyrone; aminopyrine; DNA;
D O I
10.1016/0306-3623(95)02066-7
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1. The morphological and biochemical action of dipyrone (N-[2,3-dimethyl-5-oxo-1-phenyl-3-pyrazolin-4-yl] methylamino methanesulfonate, sodium monohydrate) on the placenta of albino rats was studied by means of karyometry of trophoblastic giant cells and by determinations of DNA, RNA and total protein contents. 2. The animals were treated with a single daily dose of 50 mg/kg body weight during 5 different periods: from the 9th to the 12th, 11th to the 14th, 13th to the 16th, 15th to the 18th or 17th to the 20th day of pregnancy, 3. Karyometric results showed that the nuclear volumes of placental cells in rats treated with dipyrone during the first 3 periods were significantly greater than in control animals and that, closer to term, no differences were observed in this regard. Only the animals treated from the 9th to the 12th day of pregnancy had higher placental contents of DNA, RNA and protein than the corresponding controls. 4. Our results showed that dipyrone had a blocking effect on placental cell division which occurs mainly in the initial steps of placental development.
引用
收藏
页码:505 / 507
页数:3
相关论文
共 26 条
[1]  
BAKKE OM, 1974, ACTA PHARMACOL TOX, V35, P91
[2]  
BONALY J, 1970, ANN PHARM FR, V28, P677
[3]  
DEYSSON G, 1949, CR HEBD ACAD SCI, V228, P1306
[4]  
DEYSSON G, 1949, CR HEBD ACAD SCI, V228, P1047
[5]  
DEYSSON G, 1972, J MICROSC-PARIS, V13, P207
[6]  
DEYSSON G, 1972, CR SOC BIOL, V116, P780
[7]  
Duval M., 1891, J ANAT PHYSL PARIS, V27, P24
[8]  
DUVAL M, 1891, J ANAT, V417, P24
[9]   EFFECTS OF PH ON ANTIPYRINE TRANSFER ACROSS THE HUMAN PLACENTA EXVIVO [J].
GIROUX, M ;
CAMPISTRON, G ;
FAURE, F ;
DUMAS, JC ;
COULAIS, Y ;
DESPRATS, R ;
GRANDJEAN, H ;
HOUIN, G ;
PONTONNIER, G .
DEVELOPMENTAL PHARMACOLOGY AND THERAPEUTICS, 1990, 14 (03) :153-160
[10]  
Goodman L.S., 1980, The Pharmacological Basis of Therapeutics, V6th